Calithera Biosciences Investor Relations Material
Latest events
Q3 2022
Calithera Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Calithera Biosciences Inc
Access all reports
Calithera Biosciences Inc. is a clinical-stage biotechnology company focused on discovering and developing small-molecule therapies targeting cancer and other debilitating diseases. The company’s research is centered on developing drugs that inhibit tumor metabolism and modulate the immune system to treat cancer and other conditions. Calithera’s lead programs involve targeting metabolic pathways in tumor cells and immune cells to improve patient outcomes. The company is headquartered in South San Francisco, California, USA, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CALA
Country
🇺🇸 United States